Use of antagonist pathway for the treatment and / or prevention of Sleep Disorders by Phase Change and Pharmaceutical composition comprising Said antagonist.USO DE UN ANTAGONISTA DEL RECEPTOR DE VASOPRESINA V1A DERIVADO DE TRIAZOLO BENZODIAZEPINA PARA TRATAR EL TRASTORNO DEL SUEÑO POR CAMBIO DE FASE.